לתמיכה טכנית: אנג'לה 054-2405612

Simbrinza:

disclaimer
Posology: Use in adults, including the elderly 
The recommended dose is one drop of SIMBRINZA in the affected eye(s) two times daily. 

רופא יקר, למידע נוסף אנא עיין בעלון התכשיר כפי שאושר ע"י משרד הבריאות

01

Gandolfi, Stefano A., et al. "Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension." Advances in therapy 31.12 (2014): 1213-1227.‏

Nevanac:

Disclaimer:
Nevanac prescribing information: 
Posology: Udults, including the elderly For the prevention and treatment of pain and inflammation, the dose is 1 drop of NEVANAC in the conjunctival sac of the affected eye(s) 3 times daily beginning 1 day prior to cataract surgery, continued on the day of surgery and up to 21 days of the postoperative period, as directed by the clinician. An additional drop should be administered 30 to 120 minutes prior to surgery. for the reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients, the dose is 1 drop of NEVANAC in the conjunctival sac of the affected eye(s) 3 times daily beginning 1 day prior to cataract surgery, continued on the day of surgery and up to 60 days of the postoperative period as directed by the clinician. An additional drop should be administered 30 to 120 minutes prior to surgery.

המינון הרשום לשימוש:
Nepafenac 1%. 

רופא יקר, למידע נוסף אנא עיין בעלון התכשיר כפי שאושר ע"י משרד הבריאות

01

Singh, Rishi, et al. "Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy." Clinical Ophthalmology (Auckland, NZ) 6 (2012): 1259.

02

Lindstrom, Richard, and Terry Kim. "Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac." Current medical research and opinion 22.2 (2006): 397-404.‏

מאמרים

Nevanac

Therapeutic indications 

NEVANAC is indicated in adults for: 
- Prevention and treatment of postoperative pain and inflammation associated with cataract surgery 
- Reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Simbrinza

Therapeutic indications 

Decrease of elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction